Ameloblastoma: Current Etiopathological Concepts and Management

Abstract

Ameloblastoma is a benign odontogenic tumor of epithelial origin. It is locally aggressive with unlimited growth capacity and has a high potential for malignant transformation as well as metastasis. Ameloblastoma has no established preventive measures although majority of patients are between ages 30 to 60 years.

Molecular and genetic factors that promote oncogenic transformation of odontogenic epithelium to ameloblastoma are strongly linked to dysregulation of multiple genes associated with mitogen activated protein kinase, sonic hedgehog and WNT/β-catenin signaling pathways. Treatment of ameloblastoma is focused on surgical resection with a wide margin of normal tissue because of its high propensity for loco-regional invasion; but this is often associated with significant patient morbidity.

The relatively high recurrence rate of ameloblastoma is influenced by the type of molecular etiologic factors, the management approach and how early the patient presents for treatment. It is expected that further elucidation of molecular factors that orchestrate pathogenesis and recurrence of ameloblastoma will lead to new diagnostic markers and targeted drug therapies for ameloblastoma.

This article is protected by copyright. All rights reserved.

http://ift.tt/2kSr5nL